Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Lluis Tort Bardolet

Lluis Tort Bardolet

Institutions of which they are part

Protein kinases in cancer research
Vall Hebron Institut de Recerca
Lluis Tort Bardolet

Lluis Tort Bardolet

Lluis Tort Bardolet

Institutions of which they are part

Protein kinases in cancer research
Vall Hebron Institut de Recerca

Related news

Laboratori de Sarcomes Infantils

New therapeutic target for an aggressive childhood cancer affecting the muscles

The research team has shown that inhibiting the TRIB3 protein slows the growth of rhabdomyosarcoma and improves survival in animal models.

Dr. José Miguel Lizcano i Dr. Sergio Espinosa

Study identifies strategy to avoid resistance to cancer therapy

A team from Vall d'Hebron Research Institute (VHIR) and the Autonomous University of Barcelona (UAB) highlights the ERK5 protein as a key factor in the resistance to cancer drugs.

Investigador i microscopi

Translational research in cancer to improve the survival and quality of life of patients

On World Cancer Research Day, we highlight the oncology research model of the Vall d'Hebron Campus that allows laboratory results to be transferred as quickly as possible to clinical practice.

See more

Related professionals

Monica Bolufer Cardona

Monica Bolufer Cardona

Predoctoral researcher
Nephrology and kidney transplantation
Read more
Macarena González Rodríguez

Macarena González Rodríguez

Read more
Milagros Fraga Pereira

Milagros Fraga Pereira

Research assistant
Clinical Neuroimmunology
Read more
Alvaro Jesus Valverde Moya

Alvaro Jesus Valverde Moya

Predoctoral researcher
Molecular Medical Imaging
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.